Chemical formula: C₁₇H₁₉N₃  Molecular mass: 265.353 g/mol  PubChem compound: 2200

Active ingredient description

Antazoline is an antagonist of histamine H1 receptors. It selectively bind to but does not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
R01AC04 Antazoline R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AC Antiallergic agents, excl. corticosteroids
Discover more medicines within R01AC04
R06AX05 Antazoline R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AX Other antihistamines for systemic use
Discover more medicines within R06AX05

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 2508-72-7
CAS Substance: 91-75-8
DrugBank Drug: DB08799
KEGG Drug: D07458
PubChem Compound: 2200
RxNorm Ingredient: 865
SNOMED-CT Concept: 373544004
Antazoline (substance)
UNII Identifier: DHA8014SS1

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.